Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
MVM Partners
AddedFeb 13, 2024
UpdatedJun 28, 2026
MVM Partners

MVM Partners

Operating

MVM Life Science Partners: A global venture capital firm investing in healthcare and pharmaceutical sectors.

Location
London, Greater London, GB
Founded
2005
Firm
Compare
Portfolio
Employees
Website

MVM Partners is a global venture capital firm specializing in healthcare investments. With teams in Boston and London, the firm focuses on medical technology, pharmaceuticals, diagnostics, contract research and manufacturing, digital health, and other healthcare sectors. MVM typically invests in Series B to Series E rounds, with a broad investment outlook spanning various stages of company growth.

The firm's portfolio includes notable companies such as Cara Therapeutics, GT Medical Technologies, and Vero Biotech. MVM partners with management teams to bring innovative products to market, drive growth, and make strategic acquisitions. With over $1 billion in assets under management and extensive experience in healthcare investing, MVM offers valuable expertise and support to its portfolio companies.

MVM Partners - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments27
Current Portfolio Count17
Total Portfolio Exits1

Top Investment Stages

Series Unknown6 (24.0%)
Series B5 (20.0%)
Series C5 (20.0%)
Series D5 (20.0%)
Series E4 (16.0%)

Stage Mix

Series Unknown 24%Series B 20%Series C 20%Series D 20%Series E 16%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Nalu Medical logo

Nalu Medical

Gynesonics logo

Gynesonics

CurvaFix logo

CurvaFix

GT Medical Technologies logo

GT Medical Technologies

Ossio logo

Ossio

Neurolens logo

Neurolens

Vero Biotech logo

Vero Biotech

Inbrace logo

Inbrace

Paragon 28 logo

Paragon 28

Providence Medical Technology logo

Providence Medical Technology

Zipline Medical logo

Zipline Medical

Vital Connect logo

Vital Connect

Vertos Medical logo

Vertos Medical

Ambiopharm logo

Ambiopharm

Tarsa Therapeutics logo

Tarsa Therapeutics

Cara Therapeutics logo

Cara Therapeutics

AccuVein logo

AccuVein

Solx logo

Solx

MVM Partners - Similar Investment Firms

MPM Capital logo

MPM Capital

mpmbioimpact.com

MMV Financial logo

MMV Financial

TVM Capital logo

TVM Capital

tvm-capital.com

Maverick Ventures logo

Maverick Ventures

Miven Venture Partners logo

Miven Venture Partners

Merlin Ventures logo

Merlin Ventures

merlin.vc

Vitruvian Partners logo

Vitruvian Partners

Vida Ventures logo

Vida Ventures

vidaventures.com

Morgenthaler logo

Morgenthaler

mvp Capital logo

mvp Capital

MV Advisers logo

MV Advisers

mosaicventures.com

BV Investment Partners logo

BV Investment Partners

bvlp.com

Summit Partners logo

Summit Partners

summitpartners.com

Healthcare Ventures logo

Healthcare Ventures

hcven.com

LifeSci Venture Partners logo

LifeSci Venture Partners

lifesciventure.com

MVM Partners - Classification

Also Known As
  • MVM Partners LLP
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end